Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
2020 | RavenQuest BioMed Inc. announced that it has received CAD 0.480718 million in funding | CI |
2020 | RavenQuest BioMed Inc. announced that it expects to receive CAD 1 million in funding | CI |
Sales 2017 | 0.11 8.91 | Sales 2018 | 1.26 99.65 | Capitalization | 58.71M 4.65B |
---|---|---|---|---|---|
Net income 2017 | -3M -238M | Net income 2018 | -30M -2.38B | EV / Sales 2017 * | - |
Net cash position 2017 | 3.15M 250M | Net Debt 2018 | 12.9M 1.02B | EV / Sales 2018 | 56,975,119 x |
P/E ratio 2017 * |
-
| P/E ratio 2018 |
-1.55
x | Employees | - |
Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 89.48% |
Managers | Title | Age | Since |
---|---|---|---|
Jay Dhaliwal
CEO | Chief Executive Officer | 35 | 26/11/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jay Dhaliwal
CEO | Chief Executive Officer | 35 | 26/11/19 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 182 | |
+10.90% | 7.75B | |
-34.94% | 3.23B | |
-2.28% | 1.57B | |
-9.84% | 1.08B | |
+23.26% | 851M | |
-10.65% | 707M | |
-4.92% | 598M | |
-13.76% | 573M | |
-13.07% | 525M |
- Stock Market
- Equities
- RVVQF Stock